Tristel plc (FRA:R1V)

Market Cap	232.07M +1.8%
Revenue (ttm)	54.20M +10.8%
Net Income	7.75M +2.3%
EPS	0.16 +2.1%
Shares Out	n/a
PE Ratio	29.96
Forward PE	24.51
Dividend	0.16 (3.73%)
Ex-Dividend Date	Nov 27, 2025

Volume	n/a
Average Volume	81
Open	4.420
Previous Close	4.420
Day's Range	4.420 - 4.420
52-Week Range	3.040 - 5.050
Beta	n/a
RSI	55.42
Earnings Date	Feb 24, 2026

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wip...

• Industry: Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 1993
• Employees: 267
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: R1V

Financial Performance

In fiscal year 2025, Tristel's revenue was 46.46 million, an increase of 10.80% compared to the previous year's 41.93 million. Earnings were 6.64 million, an increase of 2.33%.

Financial numbers in GBP